n.a. (ZMH)

pos +0.00
Today's Range: 0.00 - 0.00 | ZMH Avg Daily Volume: 0
Last Update: 12/31/69 - 7:00 PM EST
Volume: 0
YTD Performance: 0.00%
Open: $0.00
Previous Close: $0.00
52 Week Range: $0.00 - $0.00
Oustanding Shares: 170,402,000
Market Cap: 0
6-Month Chart
TheStreet Ratings Grade for ZMH
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy
Moderate Buy
Moderate Sell
Strong Sell
Mean Rec. 0.00 0.00 0.00 0.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
ZMH Sector Avg. S&P 500
0.00 0.00 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
Revenue 0.00 0.00 0.00
Net Income 0.00 0.00 0.00
EPS 0.00 0.00 0.00
Earnings for ZMH:
Revenue 0.00B
Average Earnings Estimates

Earnings Estimates data is not available for ZMH.

Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Point and figure price projections measure as high as $188 for ZBH.
Jun 25, 2015 | 6:43 AM EDT
ZMH was downgraded from Buy to Hold, Brean Capital said. Company lacks near-term catalysts. 
Investors should step up even before Biomet acquisition OK'd.
May 04, 2015 | 8:29 AM EDT
ZMH estimates were reduced through 2016, BMO Capital said. Management lowered guidance. Outperform rating and new $132 price target.&nb...
May 01, 2015 | 8:00 AM EDT
Shares of ZMH now seen reaching $130, according to Leerink Partners. Estimates also cut, given the stronger dollar. Outperform rating.&...
Feb 03, 2015 | 7:24 AM EST
ZMH was upgraded from Hold to Buy, Jefferies said. Valuation call, based on a $131 price target. 
Jan 30, 2015 | 6:28 AM EST
ZMH was downgraded from Strong Buy to Buy, Needham said. Valuation call, based on a $131 price target. 
Jan 05, 2015 | 7:16 AM EST
ZMH was upgraded from Neutral to Overweight, JP Morgan said. $136 price target. Management can unlock value, by integrating the Biomet ...
Jan 05, 2015 | 6:39 AM EST
ZMH was upgraded from Equal-weight to Overweight, Morgan Stanley said. $134 price target. Valuation call, as Biomet should help drive g...
Throughout this historic run, four groups have consistently led the market.

Columnist Conversations

Now that AAPL has violated the shorter term support, these are the two areas I have to consider for new buy en...
The symmetry is holding up in MCD.  Target 1 is 163.34 if we continue to hold above here!  ...
As far as TSLA is concerned, I still have a higher target above the market at the 409 area.  I stated in ...
The TLT setup discussed in my last commentary is a bust. Key support was violated and it violated the recent l...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.